Since both α-CTLA-4 and α-PD-1 treatment increase tumour T-cell infiltration in mouse and human22, 23, 24, we examined the abundance of CD4+ and CD8+ T cells in MB49 tumours treated with α-CTLA-4, α-PD-1 or combination therapy. Here, CD4 is linked to neoplasm.